As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: November 5, 2014
by Lynn Posluns, Founder & President, Women’s Brain Health Initiative:
Women’s Brain Health Initiative (WBHI) is joining a national 5-year research program to enhance scientific understanding of dementia and other neurodegenerative diseases, with particular emphasis on women. Announced earlier this fall by Health Minister Rona Ambrose, the consortium of Canada’s best and brightest neuro-scientists hopes to discover more effective brain-aging disease treatments and prevention strategies.
Thanks to millions of dollars from the Canadian government and 13 partners from the public and private sectors, including WBHI, the Canada-wide initiative, Canadian Consortium on Neurodegeneration in Aging (CCNA), brings together 20 research teams and 340 scientists and medical professionals to focus research on 3 topics:
Because of WBHI’s support, the CCNA now includes a Women and Dementia Core, a cross-cutting theme to ensure sex and gender are taken into account by the researchers involved across the 3 topics. This is important to better understand the unique risks for the two sexes, why differences exist, what the different outcomes are and whether they should be treated differently.
According to the Alzheimer’s Society, 62% of Alzheimer’s sufferers today are women and if no solutions are found, this number will grow to 70%. We couldn’t ignore a number this big. Can you? Join our fight to combat brain aging diseases that affect women by donating or sharing your story, and prove our grey matter matters.
Thirty-six million people worldwide suffer from Alzheimer’s disease and dementia. In Canada, 25,000 new cases are diagnosed each year. Those sobering numbers have researchers around the globe racing to come up with new ways to...
he Food and Drug Administration issued new guides on drug development for neurological disorders. This sets the stage for possible treatments for Alzheimer’s. The disease-oriented development guide documents will provide details on how researchers...
For young adults with autosomal dominant Alzheimer’s disease (AD), molecular markers can identify changes associated with the disease before clinical onset, according to a study published online Feb. 12 in JAMA Neurology. Yakeel T. Quiroz, Ph.D., from Massachusetts...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.